Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cue Biopharma Granted U.S. Patent #11,370,821 T-cell modulatory multimeric polypeptides and methods of use thereof

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5531&f=G&l=50&d=PTXT&p=111&S1=20220628&OS=20220628&RS=20220628"> https://patft.uspto.gov/netacgi/nph-Parser?Sect1=
byCharles Gross
June 28, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5531&f=G&l=50&d=PTXT&p=111&S1=20220628&OS=20220628&RS=20220628″> https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5531&f=G&l=50&d=PTXT&p=111&S1=20220628&OS=20220628&RS=20220628

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Embraer: Q2 Earnings Insights

By Benzinga Insights
Today, 10:52 PM
  Shares of Embraer (NYSE:ERJ) moved higher by 4.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 122.22% over the past year to $0.24, which beat the estimate of ($0.28).

ERJ